I agree that this site is using cookies. You can find further informations here.
X
de Weerdt, O.
79  results:
Search for persons X
?
1

Determinants of lenalidomide response with or without eryth..:

van de Loosdrecht, A. A. ; Cremers, E. M. P. ; Alhan, C....
Leukemia.  38 (2024)  4 - p. 840-850 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Addition of the nuclear export inhibitor selinexor to stand..:

Janssen, J. J. W. M. ; Löwenberg, B. ; Manz, M....
Leukemia.  36 (2022)  9 - p. 2189-2195 , 2022
Link: https://doi.org/10.1038/..
 
?
3

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THER..:

Rijneveld, A. ; Gradowska, P. ; Bellido, M....
HemaSphere.  6 (2022)  - p. 266-267 , 2022
Link: https://doi.org/10.1097/..
 
?
4

Correction: Lenalidomide added to standard intensive treatm..:

Ossenkoppele, G. J. ; Breems, D. A. ; Stuessi, G....
Leukemia.  34 (2020)  10 - p. 2820-2820 , 2020
Link: https://doi.org/10.1038/..
 
?
5

Lenalidomide added to standard intensive treatment for olde..:

Ossenkoppele, G. J. ; Breems, D. A. ; Stuessi, G....
Leukemia.  34 (2020)  7 - p. 1751-1759 , 2020
Link: https://doi.org/10.1038/..
 
?
6

Elastic compression stockings one year after DVT diagnosis:..:

Mol, G.C. ; Dronkers, C.E.A. ; van de Ree, M.A....
Thrombosis Research.  173 (2019)  - p. 35-41 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Efficacy of cisplatin-based immunochemotherapy plus alloSCT..:

van Gelder, M ; van Oers, M H ; Alemayehu, W G...
Bone Marrow Transplantation.  51 (2016)  6 - p. 799-806 , 2016
Link: https://doi.org/10.1038/..
 
?
8

Real-world costs of chronic lymphocytic leukaemia in the Ne..:

Holtzer-Goor, K.M. ; Bouwmans-Frijters, C.A.M. ; Schaafsma, M.R....
Leukemia Research.  38 (2014)  1 - p. 84-90 , 2014
Link: https://doi.org/10.1016/..
 
?
9

Azacitidine results in comparable outcome in newly diagnose..:

van der Helm, L.H. ; Veeger, N.J.G.M. ; Kooy, M. van Marwijk...
Leukemia Research.  37 (2013)  8 - p. 877-882 , 2013
Link: https://doi.org/10.1016/..
 
?
10

190 Efficacy of azacitidine and predictive factors for resp..:

van der Helm, L. ; Alhan, C. ; Wijermans, P.W....
Leukemia Research.  35 (2011)  - p. S75 , 2011
Link: https://doi.org/10.1016/..
 
?
11

Response to conjugate pneumococcal and Haemophilus influenz..:

Meerveld-Eggink, A. ; de Weerdt, O. ; van Velzen-Blad, H...
Vaccine.  29 (2011)  4 - p. 675-680 , 2011
Link: https://doi.org/10.1016/..
 
?
12

Impaired antibody response to conjugated meningococcal sero..:

Meerveld-Eggink, A. ; Weerdt, O. ; Voer, R. M....
European Journal of Clinical Microbiology & Infectious Diseases.  30 (2010)  5 - p. 611-618 , 2010
Link: https://doi.org/10.1007/..
 
?
13

B152 First Analysis of HOVON-65/GMMG-HD4 Randomized Phase I..:

Sonneveld, P ; Eljarari, L ; Salwender, H...
Clinical Lymphoma and Myeloma.  9 (2009)  - p. S105-S106 , 2009
Link: https://doi.org/10.1016/..
 
?
14

A046 HOVON-50 Final Analysis of Thalidomide Combined with A..:

Lokhorst, H ; van der Holt, B ; Zweegman, S...
Clinical Lymphoma and Myeloma.  9 (2009)  - p. S8 , 2009
Link: https://doi.org/10.1016/..
 
?
15

Vaccination coverage and awareness of infectious risks in p..:

Meerveld-Eggink, A. ; de Weerdt, O. ; Rijkers, G.T...
Vaccine.  26 (2008)  52 - p. 6975-6979 , 2008
Link: https://doi.org/10.1016/..
 
1-15